Suppr超能文献

延胡索属植物对肠道蠕动、通便和痉挛的促动、松弛和痉挛作用的种属和组织特异性。

Species and tissue-specificity of prokinetic, laxative and spasmodic effects of Fumaria parviflora.

机构信息

Natural Product Research Division, Department of Biological and Biomedical Sciences, The Aga Khan University Medical College, Karachi 74800, Pakistan.

出版信息

BMC Complement Altern Med. 2012 Mar 10;12:16. doi: 10.1186/1472-6882-12-16.

Abstract

BACKGROUND

Fumaria parviflora Linn. (Fumariaceae), is a small branched annual herb found in many parts of the world including Saudi Arabia and Pakistan. This study was designed to provide pharmacological basis for the medicinal use of Fumaria parviflora in gut motility disorders.

METHODS

The in-vivo prokinetic and laxative assays were conducted in mice. Isolated intestinal preparations (ileum and jejunum) from different animal species (mouse, guinea-pig and rabbit) were separately suspended in tissue baths containing Tyrode's solution bubbled with carbogen and maintained at 37°C. The spasmogenic responses were recorded using isotonic transducers coupled with PowerLab data acquisition system.

RESULTS

The aqueous-methanol extract of Fumaria parviflora (Fp.Cr), which tested positive for the presence of alkaloids, saponins, tannins and anthraquinones showed partially atropine-sensitive prokinetic and laxative activities in the in-vivo in mice at 30 and 100 mg/kg. In the in-vitro studies, Fp.Cr (0.01-1 mg/ml) caused a concentration-dependent atropine-sensitive stimulatory effect both in mouse tissues (jejunum and ileum), and rabbit jejunum but had no effect in rabbit ileum. In guinea-pig tissues (ileum and jejunum), the crude extract showed a concentration-dependent stimulatory effect with higher efficacy in ileum and the effect was partially blocked by atropine, indicating the involvement of more than one types of gut-stimulant components (atropine-sensitive and insensitive). This could be a plausible reason for the greater efficacy of Fp.Cr in gut preparations of guinea-pig than in rabbit or mouse.

CONCLUSIONS

This study shows the prokinetic, laxative and spasmodic effects of the plant extract partially mediated through cholinergic pathways with species and tissue-selectivity, and provides a sound rationale for the medicinal use of Fumaria parviflora in gut motility disorders such as, indigestion and constipation. This study also suggests using different species to know better picture of pharmacological profile of the test material.

摘要

背景

紫堇属(罂粟科)是一种小型分枝的一年生草本植物,分布于世界各地,包括沙特阿拉伯和巴基斯坦。本研究旨在为紫堇在肠道动力障碍中的药用提供药理学依据。

方法

在小鼠中进行体内促动力和通便作用试验。分别从不同动物物种(小鼠、豚鼠和兔)分离的肠段(回肠和空肠)悬浮于含有胎牛血清的组织浴槽中,并用碳化氧气体充气,并保持在 37°C。使用与 PowerLab 数据采集系统相连的张力换能器记录痉挛反应。

结果

紫堇的水-甲醇提取物(Fp.Cr),经检测含有生物碱、皂苷、单宁和蒽醌,在 30 和 100mg/kg 时在体内对小鼠表现出部分阿托品敏感的促动力和通便作用。在体外研究中,Fp.Cr(0.01-1mg/ml)在 0.01-1mg/ml 浓度范围内引起浓度依赖性的阿托品敏感刺激作用,无论是在小鼠组织(空肠和回肠)还是在兔空肠中,但在兔回肠中没有作用。在豚鼠组织(回肠和空肠)中,粗提物显示出浓度依赖性的刺激作用,在回肠中的作用更强,该作用部分被阿托品阻断,表明存在不止一种类型的肠道刺激成分(阿托品敏感和不敏感)。这可能是 Fp.Cr 在豚鼠肠道制剂中比在兔或鼠中更有效的一个合理原因。

结论

本研究表明植物提取物具有促动力、通便和痉挛作用,部分通过胆碱能途径介导,具有种属和组织选择性,并为紫堇在肠道动力障碍如消化不良和便秘中的药用提供了合理依据。本研究还表明,使用不同的物种可以更好地了解测试材料的药理学特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/3324389/eb7ca56e2259/1472-6882-12-16-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验